SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689375-23-000072
Filing Date
2023-11-07
Accepted
2023-11-07 07:08:39
Documents
14
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trda-20231107.htm   iXBRL 8-K 29311
2 EX-99.1 trdaq32023results.htm EX-99.1 60853
6 image_0a.jpg GRAPHIC 30141
  Complete submission text file 0001689375-23-000072.txt   274419

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20231107.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20231107_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20231107_pre.xml EX-101.PRE 13585
8 EXTRACTED XBRL INSTANCE DOCUMENT trda-20231107_htm.xml XML 2928
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 231381523
SIC: 2834 Pharmaceutical Preparations